Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
+0.99 (1.18%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 83.80 - 85.16
52 week 59.65 - 85.16
Open 84.22
Vol / Avg. 1.13M/1.37M
Mkt cap 12.16B
P/E 16.47
Div/yield 0.40/1.88
EPS 5.16
Shares 141.46M
Beta 0.72
Inst. own 97%
Oct 20, 2016
Q3 2016 Quest Diagnostics Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 12, 2016
Quest Diagnostics Inc at Morgan Stanley Global Healthcare Conference Add to calendar
Aug 10, 2016
Quest Diagnostics Inc at Canaccord Genuity Growth Conference - 10:30AM EDT - Add to calendar
Aug 8, 2016
Quest Diagnostics Inc at Pacific Crest Global Technology Leadership Forum - 2:30PM EDT - Add to calendar
Jul 21, 2016
Q2 2016 Quest Diagnostics Inc Earnings Release
Jul 21, 2016
Q2 2016 Quest Diagnostics Inc Earnings Call - Webcast
Jun 7, 2016
Quest Diagnostics Inc at Goldman Sachs Global Healthcare Conference
May 18, 2016
Quest Diagnostics Inc Annual Shareholders Meeting
May 13, 2016
Quest Diagnostics Inc Annual Shareholders Meeting (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 6.12% 10.05%
Operating margin 13.79% 18.67%
EBITD margin - 18.79%
Return on average assets 4.56% 7.60%
Return on average equity 8.78% 15.72%
Employees 44,000 -
CDP Score - 89 D


3 Giralda Farms
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company's Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, employers and others. The Company's Diagnostic Solutions offers a range of solutions for insurers and healthcare providers. The Company provides risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians' health information technology solutions and diagnostic products. ExamOne provides risk assessment services to the life insurance industry in North America. ChartMaxx is the Company's enterprise content management system for hospitals.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Group Executive - Diagnostic Solutions
Age: 61
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 49
Bio & Compensation  - Reuters
James E. Davis Senior Vice President ,Group Executive - Regional Businesses
Age: 53
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President and Group Executive - Clinical Franchise Solutions
Age: 53
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Jenne K. Britell Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters
Vicky B. Gregg Independent Director
Age: 61
Bio & Compensation  - Reuters